Report Detail

Pharma & Healthcare Global Pet Veterinary Drug Market Growth 2019-2024

  • RnM3574918
  • |
  • 05 July, 2019
  • |
  • Global
  • |
  • 132 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global pet veterinary drug market is divided into drugs and biological agents and vaccines according to drugs. According to the ingredients, it is divided into anti-infectives, anti-inflammatory drugs, parasiticides, analgesics and sedatives. Due to the significant growth of the global healthcare industry, global demand for pet veterinary drugs is increasing.

According to this study, over the next five years the Pet Veterinary Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pet Veterinary Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Veterinary Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Pet Veterinary Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Veterinary Hospitals
Veterinary Clinics
Drug Stores

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pet Veterinary Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pet Veterinary Drug market by identifying its various subsegments.
Focuses on the key global Pet Veterinary Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pet Veterinary Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pet Veterinary Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Pet Veterinary Drug Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Pet Veterinary Drug Consumption 2014-2024
        • 2.1.2 Pet Veterinary Drug Consumption CAGR by Region
      • 2.2 Pet Veterinary Drug Segment by Type
        • 2.2.1 Anti-Infectives
        • 2.2.2 Anti-Inflammatory
        • 2.2.3 Parasiticides
        • 2.2.4 Analgesics
        • 2.2.5 Sedatives
        • 2.2.6 Others
      • 2.3 Pet Veterinary Drug Consumption by Type
        • 2.3.1 Global Pet Veterinary Drug Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Pet Veterinary Drug Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Pet Veterinary Drug Sale Price by Type (2014-2019)
      • 2.4 Pet Veterinary Drug Segment by Application
        • 2.4.1 Veterinary Hospitals
        • 2.4.2 Veterinary Clinics
        • 2.4.3 Drug Stores
      • 2.5 Pet Veterinary Drug Consumption by Application
        • 2.5.1 Global Pet Veterinary Drug Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Pet Veterinary Drug Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Pet Veterinary Drug Sale Price by Application (2014-2019)

      3 Global Pet Veterinary Drug by Manufacturers

      • 3.1 Global Pet Veterinary Drug Sales Market Share by Manufacturers
        • 3.1.1 Global Pet Veterinary Drug Sales by Manufacturers (2017-2019)
        • 3.1.2 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2017-2019)
      • 3.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers
        • 3.2.1 Global Pet Veterinary Drug Revenue by Manufacturers (2017-2019)
        • 3.2.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2017-2019)
      • 3.3 Global Pet Veterinary Drug Sale Price by Manufacturers
      • 3.4 Global Pet Veterinary Drug Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
        • 3.4.1 Global Pet Veterinary Drug Manufacturing Base Distribution and Sales Area by Manufacturers
        • 3.4.2 Players Pet Veterinary Drug Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Pet Veterinary Drug by Regions

      • 4.1 Pet Veterinary Drug by Regions
        • 4.1.1 Global Pet Veterinary Drug Consumption by Regions
        • 4.1.2 Global Pet Veterinary Drug Value by Regions
      • 4.2 Americas Pet Veterinary Drug Consumption Growth
      • 4.3 APAC Pet Veterinary Drug Consumption Growth
      • 4.4 Europe Pet Veterinary Drug Consumption Growth
      • 4.5 Middle East & Africa Pet Veterinary Drug Consumption Growth

      5 Americas

      • 5.1 Americas Pet Veterinary Drug Consumption by Countries
        • 5.1.1 Americas Pet Veterinary Drug Consumption by Countries (2014-2019)
        • 5.1.2 Americas Pet Veterinary Drug Value by Countries (2014-2019)
      • 5.2 Americas Pet Veterinary Drug Consumption by Type
      • 5.3 Americas Pet Veterinary Drug Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Pet Veterinary Drug Consumption by Countries
        • 6.1.1 APAC Pet Veterinary Drug Consumption by Countries (2014-2019)
        • 6.1.2 APAC Pet Veterinary Drug Value by Countries (2014-2019)
      • 6.2 APAC Pet Veterinary Drug Consumption by Type
      • 6.3 APAC Pet Veterinary Drug Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Pet Veterinary Drug by Countries
        • 7.1.1 Europe Pet Veterinary Drug Consumption by Countries (2014-2019)
        • 7.1.2 Europe Pet Veterinary Drug Value by Countries (2014-2019)
      • 7.2 Europe Pet Veterinary Drug Consumption by Type
      • 7.3 Europe Pet Veterinary Drug Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Pet Veterinary Drug by Countries
        • 8.1.1 Middle East & Africa Pet Veterinary Drug Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Pet Veterinary Drug Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Pet Veterinary Drug Consumption by Type
      • 8.3 Middle East & Africa Pet Veterinary Drug Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Pet Veterinary Drug Distributors
      • 10.3 Pet Veterinary Drug Customer

      11 Global Pet Veterinary Drug Market Forecast

      • 11.1 Global Pet Veterinary Drug Consumption Forecast (2019-2024)
      • 11.2 Global Pet Veterinary Drug Forecast by Regions
        • 11.2.1 Global Pet Veterinary Drug Forecast by Regions (2019-2024)
        • 11.2.2 Global Pet Veterinary Drug Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Pet Veterinary Drug Forecast by Type
      • 11.8 Global Pet Veterinary Drug Forecast by Application

      12 Key Players Analysis

      • 12.1 Boehringer Ingelheim International GmbH
        • 12.1.1 Company Details
        • 12.1.2 Pet Veterinary Drug Product Offered
        • 12.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Boehringer Ingelheim International GmbH News
      • 12.2 Zoetis Animal Healthcare
        • 12.2.1 Company Details
        • 12.2.2 Pet Veterinary Drug Product Offered
        • 12.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Zoetis Animal Healthcare News
      • 12.3 Bayer AG
        • 12.3.1 Company Details
        • 12.3.2 Pet Veterinary Drug Product Offered
        • 12.3.3 Bayer AG Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Bayer AG News
      • 12.4 Merck Animal Health
        • 12.4.1 Company Details
        • 12.4.2 Pet Veterinary Drug Product Offered
        • 12.4.3 Merck Animal Health Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Merck Animal Health News
      • 12.5 Elanco Animal Health Inc.
        • 12.5.1 Company Details
        • 12.5.2 Pet Veterinary Drug Product Offered
        • 12.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Elanco Animal Health Inc. News
      • 12.6 Virbac Group
        • 12.6.1 Company Details
        • 12.6.2 Pet Veterinary Drug Product Offered
        • 12.6.3 Virbac Group Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Virbac Group News
      • 12.7 Ceva
        • 12.7.1 Company Details
        • 12.7.2 Pet Veterinary Drug Product Offered
        • 12.7.3 Ceva Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Ceva News
      • 12.8 Dechra Pharmaceuticals Plc
        • 12.8.1 Company Details
        • 12.8.2 Pet Veterinary Drug Product Offered
        • 12.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Dechra Pharmaceuticals Plc News
      • 12.9 Vetoquinol
        • 12.9.1 Company Details
        • 12.9.2 Pet Veterinary Drug Product Offered
        • 12.9.3 Vetoquinol Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Vetoquinol News
      • 12.10 Orion Corporation
        • 12.10.1 Company Details
        • 12.10.2 Pet Veterinary Drug Product Offered
        • 12.10.3 Orion Corporation Pet Veterinary Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Orion Corporation News

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Pet Veterinary Drug. Industry analysis & Market Report on Pet Veterinary Drug is a syndicated market report, published as Global Pet Veterinary Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pet Veterinary Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,928.00
      4,392.00
      5,856.00
      3,418.44
      5,127.66
      6,836.88
      575,827.80
      863,741.70
      1,151,655.60
      305,207.40
      457,811.10
      610,414.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report